Showing results (21-30 of 48) with videos related to
Sort By:
Pageof 5
Anticancer Research|July 3, 2019
Biological Evaluation of the Antiproliferative and Anti-migratory Activity of a Series of 3-(6-Phenylimidazo[2,1-b][1,3,4]thiadiazol-2-yl)-1H-indole Derivatives Against Pancreatic Cancer CellsGiovanna Li Petri, Stella Cascioferro, Btissame El Hassouni, et al.Chemmedchem|August 25, 2025
Novel Pyrazolo [1,5-a]-1,3,5-Triazine Derivatives as CDK7 Inhibitors: Synthesis and Biological Insights in Pancreatic Ductal Adenocarcinoma ModelsDaniela Carbone, Francesca Terrana, Ludovica Sciuto, et al.International Journal of Molecular Sciences|February 25, 2023
Discovery of the 3-Amino-1,2,4-triazine-Based Library as Selective PDK1 Inhibitors with Therapeutic Potential in Highly Aggressive Pancreatic Ductal AdenocarcinomaDaniela Carbone, Michele De Franco, Camilla Pecoraro, et al.European Journal of Medicinal Chemistry|January 29, 2023
1,2,4-Amino-triazine derivatives as pyruvate dehydrogenase kinase inhibitors: Synthesis and pharmacological evaluationCamilla Pecoraro, Michele De Franco, Daniela Carbone, et al.Expert Opinion on Therapeutic Targets|October 8, 2025
CDK7 as a New therapeutic target in pancreatic and lung cancer: current evidence and future perspectivesEmilia Di Giovanni, Rita Siino, Antonio Russo, et al.Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
SF3B1 modulators affect key genes in metastasis and drug influx: a new approach to fight pancreatic cancer chemoresistanceOrnella Randazzo, Stella M Cascioferro, Camilla Pecoraro, et al.Nature Communications|August 10, 2023
HIV-1-induced nuclear invaginations mediated by VAP-A, ORP3, and Rab7 complex explain infection of activated T cellsMark F Santos, Germana Rappa, Jana Karbanová, et al.Journal of Drug Targeting|July 27, 2024
Exploring the therapeutic potential of a novel series of imidazothiadiazoles targeting focal adhesion kinase (FAK) for pancreatic cancer treatment: synthesis, mechanistic insights and promising antitumor and safety profileCamilla Pecoraro, Daniela Carbone, Fabio Scianò, et al.Molecular Informatics|August 25, 2020
Dynamic-shared Pharmacophore Approach as Tool to Design New Allosteric PRC2 Inhibitors, Targeting EED Binding PocketJessica Lombino, Maria Rita Gulotta, Giada De Simone, et al.Marine Drugs|May 26, 2023
Structural Manipulations of Marine Natural Products Inspire a New Library of 3-Amino-1,2,4-Triazine PDK Inhibitors Endowed with Antitumor Activity in Pancreatic Ductal AdenocarcinomaDaniela Carbone, Michele De Franco, Camilla Pecoraro, et al.Pageof 5